Degenerative Lumbar Spondylolisthesis

3

Review clinical trials related to Degenerative Lumbar Spondylolisthesis. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Comparison of Endoscopic Lumbar Decompression and Minimally Invasive Transforaminal Lumbar Interbody Fusion(MIS-TLIF) for Degenerative Lumbar Spondylolisthesis

Comparing the functional and radiographic outcomes in surgical treatment in failed conservative treatment, single-level low grade degenerative lumbar spondylolisthesis between Minimal Invasive Surgery Transforaminal Lumbar Interbody Fusion, which is conventional treatment recently, and Endoscopic Lumbar Decompression, which is minimal invasive in symptomatic treatment.

Participants needed: 66
Trial details
Age: 40+Biological sex: AllType: InterventionalSponsor: Queen Savang Vadhana Memorial Hospital, ThailandUpdated: Apr 22, 2025Locations: 1
Eligibility criteria

Single level lumbar degenerative spondylolisthesis (Meyerding Grading Grade I or... [+4]

Patients with severe foraminal stenosis diagnosed by MRI. [+3]

Status: Recruiting

Long-term Reoperations After Lumbar Spinal Stenosis Surgery

Severe and persisting pain and disability due to a degenerative narrowing of the spinal canal, lumbar spinal stenosis, can be operated with a simple surgical decompression. Sometimes, there is also a slippage of vertebra, degenerative spondylolisthesis. In such cases, instrumental stabilization (e.g. screws and rods) has been recommended. Even though additional fusion is more complex and riskier, and evidence in high-quality Scandinavian studies shows that it is unnecessary, decompression plus fusion is still the treatment of choice in the USA and most European countries. This reluctance to change clinical practice is mainly due to concerns about long-term results, especially higher reoperation rates among patients operated with decompression only. This register-based non-inferiority study aims to assess long-term reoperations among those treated with and without additional fusion surgery.

Participants needed: 794
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: University Hospital of North NorwayUpdated: Dec 17, 2024Locations: 1Duration: 8 Years
Eligibility criteria

operated between September 2007 and December 2015 labeled in the registry with b... [+1]

operated with an anterior approach [+5]

Status: Recruiting

Long-term Safety Trial with NVDX3

An study evaluating the long-term safety of all patients previously treated with NVDX3.

Participants needed: 15
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Novadip BiosciencesUpdated: Sep 5, 2024Locations: 1
Eligibility criteria

Patient being implanted with NVDX3. [+3]